Atlas Trials

Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH

Clinical trial NCT01406704 · TERMINATED

Trial details

NCT number
NCT01406704
Sponsor
Seoul St. Mary's Hospital
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
NASH (Non-alcoholic Steato-hepatitis)
Start date
2004-01-01
Primary completion
2010-12-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.